IBDEI1TG ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30855,1,3,0)
 ;;=3^Extreme Poverty
 ;;^UTILITY(U,$J,358.3,30855,1,4,0)
 ;;=4^Z59.5
 ;;^UTILITY(U,$J,358.3,30855,2)
 ;;=^5063134
 ;;^UTILITY(U,$J,358.3,30856,0)
 ;;=Z59.6^^123^1539^8
 ;;^UTILITY(U,$J,358.3,30856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30856,1,3,0)
 ;;=3^Low Income
 ;;^UTILITY(U,$J,358.3,30856,1,4,0)
 ;;=4^Z59.6
 ;;^UTILITY(U,$J,358.3,30856,2)
 ;;=^5063135
 ;;^UTILITY(U,$J,358.3,30857,0)
 ;;=Z59.7^^123^1539^6
 ;;^UTILITY(U,$J,358.3,30857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30857,1,3,0)
 ;;=3^Insufficient Social Insurance/Welfare Support
 ;;^UTILITY(U,$J,358.3,30857,1,4,0)
 ;;=4^Z59.7
 ;;^UTILITY(U,$J,358.3,30857,2)
 ;;=^5063136
 ;;^UTILITY(U,$J,358.3,30858,0)
 ;;=Z59.9^^123^1539^4
 ;;^UTILITY(U,$J,358.3,30858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30858,1,3,0)
 ;;=3^Housing/Economic Problems,Unspec
 ;;^UTILITY(U,$J,358.3,30858,1,4,0)
 ;;=4^Z59.9
 ;;^UTILITY(U,$J,358.3,30858,2)
 ;;=^5063138
 ;;^UTILITY(U,$J,358.3,30859,0)
 ;;=G21.19^^123^1540^11
 ;;^UTILITY(U,$J,358.3,30859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30859,1,3,0)
 ;;=3^Medication-Induced Parkinsonism NEC
 ;;^UTILITY(U,$J,358.3,30859,1,4,0)
 ;;=4^G21.19
 ;;^UTILITY(U,$J,358.3,30859,2)
 ;;=^5003773
 ;;^UTILITY(U,$J,358.3,30860,0)
 ;;=G21.11^^123^1540^14
 ;;^UTILITY(U,$J,358.3,30860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30860,1,3,0)
 ;;=3^Neuroleptic-Induced Parkinsonism
 ;;^UTILITY(U,$J,358.3,30860,1,4,0)
 ;;=4^G21.11
 ;;^UTILITY(U,$J,358.3,30860,2)
 ;;=^5003772
 ;;^UTILITY(U,$J,358.3,30861,0)
 ;;=G24.02^^123^1540^8
 ;;^UTILITY(U,$J,358.3,30861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30861,1,3,0)
 ;;=3^Medication-Induced Acute Dystonia
 ;;^UTILITY(U,$J,358.3,30861,1,4,0)
 ;;=4^G24.02
 ;;^UTILITY(U,$J,358.3,30861,2)
 ;;=^5003785
 ;;^UTILITY(U,$J,358.3,30862,0)
 ;;=G24.01^^123^1540^16
 ;;^UTILITY(U,$J,358.3,30862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30862,1,3,0)
 ;;=3^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,30862,1,4,0)
 ;;=4^G24.01
 ;;^UTILITY(U,$J,358.3,30862,2)
 ;;=^5003784
 ;;^UTILITY(U,$J,358.3,30863,0)
 ;;=G24.09^^123^1540^17
 ;;^UTILITY(U,$J,358.3,30863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30863,1,3,0)
 ;;=3^Tardive Dystonia
 ;;^UTILITY(U,$J,358.3,30863,1,4,0)
 ;;=4^G24.09
 ;;^UTILITY(U,$J,358.3,30863,2)
 ;;=^5003786
 ;;^UTILITY(U,$J,358.3,30864,0)
 ;;=G25.1^^123^1540^12
 ;;^UTILITY(U,$J,358.3,30864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30864,1,3,0)
 ;;=3^Medication-Induced Postural Tremor
 ;;^UTILITY(U,$J,358.3,30864,1,4,0)
 ;;=4^G25.1
 ;;^UTILITY(U,$J,358.3,30864,2)
 ;;=^5003792
 ;;^UTILITY(U,$J,358.3,30865,0)
 ;;=G25.71^^123^1540^15
 ;;^UTILITY(U,$J,358.3,30865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30865,1,3,0)
 ;;=3^Tardive Akathisia/Medication-Induced Acute Akatisia
 ;;^UTILITY(U,$J,358.3,30865,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,30865,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,30866,0)
 ;;=G25.79^^123^1540^10
 ;;^UTILITY(U,$J,358.3,30866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30866,1,3,0)
 ;;=3^Medication-Induced Movement Disorder NEC
 ;;^UTILITY(U,$J,358.3,30866,1,4,0)
 ;;=4^G25.79
 ;;^UTILITY(U,$J,358.3,30866,2)
 ;;=^5003800
 ;;^UTILITY(U,$J,358.3,30867,0)
 ;;=T43.205A^^123^1540^4
 ;;^UTILITY(U,$J,358.3,30867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30867,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
 ;;^UTILITY(U,$J,358.3,30867,1,4,0)
 ;;=4^T43.205A
 ;;^UTILITY(U,$J,358.3,30867,2)
 ;;=^5050540
 ;;^UTILITY(U,$J,358.3,30868,0)
 ;;=T43.205D^^123^1540^5
 ;;^UTILITY(U,$J,358.3,30868,1,0)
 ;;=^358.31IA^4^2
